1. Home
  2. ANNX vs TK Comparison

ANNX vs TK Comparison

Compare ANNX & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.39

Market Cap

812.7M

Sector

Health Care

ML Signal

HOLD

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$11.33

Market Cap

925.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
TK
Founded
2011
1973
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
812.7M
925.8M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
ANNX
TK
Price
$5.39
$11.33
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
4.4M
553.1K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
15.21%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16,320.74
N/A
P/E Ratio
N/A
$13.43
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$7.12
52 Week High
$7.18
$14.38

Technical Indicators

Market Signals
Indicator
ANNX
TK
Relative Strength Index (RSI) 47.18 52.05
Support Level $4.66 $11.25
Resistance Level $5.65 $12.50
Average True Range (ATR) 0.55 0.39
MACD -0.04 0.10
Stochastic Oscillator 28.70 97.43

Price Performance

Historical Comparison
ANNX
TK

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

Share on Social Networks: